Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy.
Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy. · Barrons.com

Bristol Myers sees revenue decline in its legacy drug portfolio due to competition and Medicare headwinds.